PETS
PetMed Express Inc
NASDAQ: PETS · HEALTHCARE · PHARMACEUTICAL RETAILERS
$2.24
-0.88% today
Updated 2026-04-30
Market cap
$48.15M
P/E ratio
—
P/S ratio
0.26x
EPS (TTM)
$-3.11
Dividend yield
—
52W range
$2 – $4
Volume
0.1M
PetMed Express Inc (PETS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-34.70%
Operating margin
-25.70%
ROE
-100.60%
ROA
-20.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $137.58M | $12.06M | 39.50% | 13.19% | 8.77% |
| 2007 | $162.25M | $14.44M | 39.80% | 13.25% | 8.90% |
| 2008 | $188.34M | $20.02M | 39.41% | 14.86% | 10.63% |
| 2009 | $219.41M | $22.98M | 38.89% | 15.59% | 10.47% |
| 2010 | $238.27M | $26.00M | 38.55% | 17.02% | 10.91% |
| 2011 | $231.64M | $20.87M | 36.24% | 14.26% | 9.01% |
| 2012 | $238.25M | $16.66M | 33.65% | 10.92% | 6.99% |
| 2013 | $227.83M | $17.16M | 33.85% | 11.85% | 7.53% |
| 2014 | $233.39M | $17.97M | 33.26% | 12.09% | 7.70% |
| 2015 | $229.40M | $17.45M | 33.25% | 12.04% | 7.61% |
| 2016 | $234.68M | $20.57M | 32.51% | 13.80% | 8.76% |
| 2017 | $249.18M | $23.82M | 31.83% | 15.04% | 9.56% |
| 2018 | $273.80M | $37.28M | 35.72% | 19.04% | 13.62% |
| 2019 | $283.42M | $37.74M | 33.63% | 16.29% | 13.32% |
| 2020 | $284.13M | $25.85M | 28.60% | 10.90% | 9.10% |
| 2021 | $303.58M | $23.92M | 27.77% | 10.06% | 7.88% |
| 2022 | $273.42M | $21.10M | 27.55% | 9.40% | 7.72% |
| 2023 | $256.58M | $5.14M | 27.68% | 2.55% | 2.00% |
| 2024 | $274.10M | $-7.46M | 28.35% | -2.54% | -2.72% |
| 2026 | $226.97M | $-6.27M | 30.46% | -0.67% | -2.76% |